Oxaliplatin, Fluorouracil and Leucovorin (FOLFOX) as First-line Chemotherapy for Metastatic or Recurrent Colorectal Cancer Patients

REFERENCES

1. ↵
   1. Pollock RE,
   2. Doroshow JH,
   3. Khayat D et al.

   1. Gil-delgado MA,
   2. Khayat D,
   3. Taieb J.

   Cancer of the Colon and Rectum. In: Pollock RE, Doroshow JH, Khayat D et al. (Eds). UICC manual of clinical oncology, 2004, 487-504.
2. ↵
   1. Levi F,
   2. Misser JL,
   3. Brienza S, et al.

   A chronopharmacologic phase II clinical trial with 5 fluorouracil, flolinic acid, and oxaliplatin using an ambulatory multichannel programmable pump, high antitumor effectiveness against metastatic colorectal cancer. Cancer 1992; 69: 893-900.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Wan DS,
   2. Pan ZZ.

   Carcinoma of Large Intestine. In: Clinical Oncology. Science Publishing House, Beijing. 2005, 346-361.
4. ↵
   1. Devita VT Jr.,
   2. Hellman S,
   3. Rosenberg SA

   1. Cohen AM,
   2. Minsky BD,
   3. Schilsky RL.

   Cancer of the Colon. In Devita VT Jr., Hellman S, Rosenberg SA (Eds). Principles and Practice of Oncology. Philadelphia, Lippincott-Raven. 1997, 1061-1125.
5. ↵
   1. Piedbois P,
   2. Buyse M,
   3. Rustum Y, et al.

   Advanced Colorectal Cancer Meta-Analysis Project: Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J Clin Oncol 1992; 10:896-903.

   OpenUrlAbstract
6. ↵
   1. Lo Bello L,
   2. Pistone G,
   3. Restuccia S, et al.

   5-fluorouracil alone versus 5-fluorouracil plus folinic acid in the treatment of colorectal carcinoma: Meta-analysis. Int J Clin Pharmacol Ther 2000; 38: 553-562.

   OpenUrlPubMed
7. ↵
   1. de Granmont A,
   2. Figer A,
   3. Seymour M, et al.

   Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938-2947.

   OpenUrlAbstract/FREE Full Text
8. ↵
   1. Goldberg RM,
   2. Sargent DJ,
   3. Morton RF, et al.

   A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004; 22:23-30.

   OpenUrlAbstract/FREE Full Text
9. 1. Colucci G,
   2. Gebbia V,
   3. Paoletti G, et al.

   Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale. J Clin Oncol 2005; 23:4866-4875.

   OpenUrlAbstract/FREE Full Text
10. ↵
    1. Tournigand C,
    2. Andre T,
    3. Achille E, et al.

    FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer. A randomized GERCOR study. J Clin Oncol 2004; 22:229-237.

    OpenUrlAbstract/FREE Full Text
11. ↵
    1. Mathe G,
    2. Kidani Y,
    3. Segiguchi M, et al.

    Oxalato-platinum or L-OHP, a third generation platinum complex: An experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum. Biomed Pharmacother 1989; 43:237-250.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    1. Sorbye H,
    2. Glimelius B,
    3. Berglund A, et al.

    Multicenter phase II study of Nordic fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 2004; 22:31-38.

    OpenUrlAbstract/FREE Full Text
13. ↵
    1. Kalofonos HP,
    2. Aravantinos G,
    3. Kosnidis P, et al.

    Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study. Ann Oncol 2005; 16:869-877.

    OpenUrlCrossRefPubMedWeb of Science